David Hale

483 total citations
9 papers, 350 citations indexed

About

David Hale is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, David Hale has authored 9 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in David Hale's work include Pain Mechanisms and Treatments (3 papers), Cannabis and Cannabinoid Research (3 papers) and Vestibular and auditory disorders (3 papers). David Hale is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Cannabis and Cannabinoid Research (3 papers) and Vestibular and auditory disorders (3 papers). David Hale collaborates with scholars based in United States. David Hale's co-authors include Nathan C. Dean, Michael Silver, Kim Bateman, Brent C. James, Daniel J. Morgan, Steven M. Donnelly, Gregory L. Snow, Josée Guindon, Diana E. Sepúlveda and Daniel R. Gold and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and The American Journal of Medicine.

In The Last Decade

David Hale

7 papers receiving 335 citations

Peers

David Hale

EPIDE

EM

PHARM

CCICM

CMN

Daniel W. Dye United States

Andrea Patton United Kingdom

Nigel Kirby United Kingdom

Cameron Wright Australia

Otis Warren United States

E. Paul Larrat United States

Cathy Voide Switzerland

Travis D. Olives United States

Susanne Moadebi Canada

Jacqueline Schwartz Germany

Daniel W. Dye United States

David Hale

85 ×0.4

EPIDE

91 ×0.8

EM

54 ×0.7

PHARM

20 ×0.3

CCICM

22 ×0.5

CMN

Citations per year, relative to David Hale David Hale (= 1×) peers Daniel W. Dye

Countries citing papers authored by David Hale

Since Specialization

Citations

This map shows the geographic impact of David Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hale more than expected).

Fields of papers citing papers by David Hale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hale. The network helps show where David Hale may publish in the future.

Co-authorship network of co-authors of David Hale

This figure shows the co-authorship network connecting the top 25 collaborators of David Hale. A scholar is included among the top collaborators of David Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hale. David Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Rieiro, Héctor, David Hale, Jorge Otero‐Millan, et al.. (2025). A Pilot Study of Smartphone Eye Tracking for Detection of Positional Nystagmus. PubMed. 9(1). 124–129.

2.

Hale, David, et al.. (2024). Evaluation of Acute Dizziness and Vertigo. Medical Clinics of North America. 109(2). 373–388.

3.

Hale, David, et al.. (2023). A review of pursuit and saccadic eye movements and their utility in stroke. SHILAP Revista de lepidopterología. 2. 1247326–1247326. 3 indexed citations

4.

Sepúlveda, Diana E., et al.. (2021). Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain. Frontiers in Molecular Biosciences. 8. 684115–684115. 17 indexed citations

5.

Hale, David, et al.. (2019). Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice. Neuropharmacology. 148. 151–159. 22 indexed citations

6.

Hale, David, et al.. (2019). Safe Placement of Ommaya Reservoirs in Thrombocytopenic Patients: One Institutions Experience. Cureus. 11(7). e5291–e5291. 2 indexed citations

7.

Hale, David, et al.. (2017). Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. Molecular Pain. 13. 2223532003–2223532003. 44 indexed citations

8.

Dean, Nathan C., Kim Bateman, Steven M. Donnelly, et al.. (2006). Improved Clinical Outcomes With Utilization of a Community-Acquired Pneumonia Guideline. CHEST Journal. 130(3). 794–799. 103 indexed citations

9.

Dean, Nathan C., et al.. (2001). Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. The American Journal of Medicine. 110(6). 451–457. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact